ANTABIO

Join us at the #EICSUMMIT25! 🌟 Meet our CEO, Marc Lemonnier, at Europe's premier event where visionary scientists, pioneering innovators, entrepreneurs, investors, and policy makers come together. 📅 Dates: April 2-3, 2025 📍 Location: Historic Tour & Taxis, Brussels Don't miss the chance to connect with Marc and discover more about ANTABIO's groundbreaking programs and investment opportunities in the #antimicrobialresistance space. #AMR #Innovation #Investment #Healthcare #Biotech #Networking European Innovation Council and SMEs Executive Agency (EISMEA) AMR Action Fund IRDI Capital Investissement BNP Paribas Turenne Groupe Relyens en France Bpifrance

We’re excited to be a member of the Presenting Company Class for the upcoming 4th East-West Biopharma Summit in Singapore. Our founding CEO Marc Lemonnier is looking forward to sharing ANTABIO’s streamlined development plans for bringing our life-saving antibacterial drug #MEM_ANT3310 to patients in Asia and the world in the coming years. #BioCenturyEastWest #antimicrobialresistance #InvestInAMR #EU_Innovation #France

We are thrilled to announce that ANTABIO will be presenting at the #GlobalIRJPM2025 event organized by KoreaBIO in marge of the #JPMorgan Healthcare Conference 2025. Join us on January 14th at 14:30 PST in San Francisco as we share our latest innovations and breakthroughs in the fight against antibiotic resistance. Don't miss this opportunity to learn more about our cutting-edge clinical program #MEM_ANT3310 and our current series C investment opportunity. See you there! #Antabio #GlobalIRJPM2025 #HealthcareInnovation #AntibioticResistance #Biotech

World AMR Awareness Week 2024 Read the EIC story, featuring ANTABIO. Progress made on our lead program #MEM_ANT3310 has been impressive, with strong support from the European Innovation Council and SMEs Executive Agency (EISMEA) #WAAW2024 #antimicrobialresistance #InvestInAMR https://lnkd.in/e5A4ecn5

Antabio is hiring a Project Manager to provide support to our Head of Program Management on the management and coordination of CMC and non-clinical development activities ! For more information: www.antabio.com/careers

We are pleased to unveil our new logo and refreshed graphic identity. Our new look represents the dynamic and forward-thinking nature of ANTABIO, as we continue to push the boundaries in the fight against #antimicrobialresistance. 🔹 New Logo: A symbol of our growth and evolution, and a reference to our field of expertise: understanding how bacteria grow, divide and express virulence/resistance factors to promote infection and cause diseases. 🔹 Graphic Identity: Modern, rigorous, and aligned with our mission to develop new drugs that can offer a lifeline to patients suffering from drug-resistant infections around the world. 👉 www.antabio.com #Antabio #NewLogo #BrandIdentity #Innovation #Growth #AMR #InvestToSaveLives

Between 2025 and 2050 #antibioticresistance is expected to kill 39 million people worldwide. Today, ANTABIO is calling on US Congress to prevent more deaths and #PassPASTEUR to combat the #superbug public health crisis. https://lnkd.in/eTmK_yc4 #PASTEURAct #AMR #antimicrobialresistance #UNGA2024

ANTABIO Announces Successful Completion of Phase 1 Clinical Study of #MEM_ANT3310 for Severe Hospital Infections ANT3310 was well-tolerated at all doses with no serious adverse events, dose-limiting toxicities or clinically relevant abnormalities reported. The ANT3310 PK parameters were consistent with those determined from studies in rodent and non-rodent species and dose-dependent increases in exposure were observed. ANT3310 and meropenem demonstrated very compatible PK with no mutual PK interaction. This positive Phase 1 data supports further patient studies of MEM-ANT3310. Read the full Press Release here: https://lnkd.in/ecEbeeU2

Un très grand honneur que ce prix coup de cœur décerné par le jury des Septuors 31. Merci! La résistance aux antibiotiques est un fléau mondial que nous combattons avec énergie et détermination, et avec le soutien indéfectible de nos partenaires locaux: Sicoval Toulouse Métropole CCI Toulouse Haute-Garonne La Région Occitanie / Pyrénées-Méditerranée IRDI Capital Investissement Bpifrance BNP Paribas Caisse d'Epargne de Midi-Pyrénées Banque Populaire A la soirée du 05 Juin au Bikini, ANTABIO sera représentée par le Président de son Conseil d'Administration Erick Lelouche. Pendant ce temps, une délégation de l'équipe Antabio avec Marc Lemonnier à sa tête suivra l'évènement depuis la Californie où se tient la BIO International Convention de San Diego. Nous sommes fiers de porter haut les couleurs de l'innovation de nos territoires, partout dans le monde! #antibiorésistance #innovation #HealthBus

Antabio is looking for a Clinical Pharmacologist to join our Clinical team ! Here is the job profile on our website: https://lnkd.in/dR5vb-T4. Contact us for further information.